More recently, a meta-analysis of six studies, including 578 BC patients and 562 healthy controls, confirmed that upregulation of UCA1 is able to predict BC (sensitivity of 81% and specificity of 86%, AUC = 0.88) [159]. Here, UCA1 is linked to breast cancer.